Related Experiment Video
Updated: Jun 21, 2026
07:18
A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice
Published on: March 2, 2019
Neuropsychological testing and assessment for dementia
Claudia Jacova1, Andrew Kertesz, Mervin Blair
1Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Summary
Brief cognitive tests and neuropsychological testing (NPT) aid in detecting mild cognitive impairment (MCI) and dementia. NPT offers valuable insights for diagnosis, risk assessment, and management decisions in cognitive decline.
Area of Science:
- Neurology
- Geriatrics
- Cognitive Science
Background:
- Cognitive complaints necessitate accurate assessment for early detection of neurodegenerative diseases.
- Distinguishing between normal aging, mild cognitive impairment (MCI), and dementia is clinically significant.
- The Mini-Mental State Exam (MMSE) has limitations in sensitivity for detecting early cognitive deficits.
Purpose of the Study:
- To review the evidence supporting the use of brief cognitive tests and neuropsychological testing (NPT) for diagnosing MCI and dementia.
- To evaluate the role of NPT in differentiating cognitive states and predicting dementia progression.
- To assess NPT's utility in differential diagnosis and guiding management strategies for cognitive impairment.
Main Methods:
- Evidence-based review of studies on cognitive screening tests and NPT.
- Analysis of diagnostic accuracy, sensitivity, and specificity of various cognitive assessments.
- Synthesis of findings regarding NPT's role in clinical decision-making for MCI and dementia.
Main Results:
- Newer brief screening tests show higher sensitivity for MCI and mild dementia than MMSE.
- NPT effectively distinguishes normal aging from MCI and early dementia, providing detailed cognitive profiles.
- NPT demonstrates fair to good accuracy in predicting progression to Alzheimer disease (AD) and other dementias.
- NPT profiles can aid in differential diagnosis of dementia etiologies, complementing neuroimaging.
- Comprehensive assessment including NPT supports management decisions, functional impact evaluation, and rehabilitation planning.
Conclusions:
- Brief cognitive tests are recommended for initial screening of cognitive complaints.
- NPT is a valuable tool in a comprehensive approach for diagnosing and managing MCI and dementia.
- NPT aids in risk stratification, differential diagnosis, and personalized treatment planning for cognitive disorders.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...